Weida TongDirector, Center for Bioinformatics FDA
Graeme HodgsonAssociate Director, Biomarkers & Translational Biology ARIAD
Oleg IartchoukGlobal Head, Next Generation Sequencing Novartis
Scott KahnChairman, Biomarkers Council International Cancer Advocacy Center (ICAN)
NGS for Cancer Drug Development is your comprehensive guide to applying NGS in cancer drug discovery and clinical diagnostic development. Hear first hand from the people who have done it. Plus get unlimited access to the latest clinical data from the genomics experts spearheading the field of cancer research.
Get immediately actionable solutions to help you choose the best technology for the smoothest transition of NGS technology towards the clinic.
You might need clarity on exactly how NGS can be applied for biomarker discovery, patient stratification or diagnostics. Or maybe an opportunity to network with oncology experts to crack the bioinformatics problems you currently face in data management and analysis.
Whatever your motivations, NGS for Cancer Drug Development is the only North American meeting this year that can truly deliver the answers.
Get more details of who is speaking and what’s being covered in the event brochure.
Connect with leaders in the industry and take back useable information for tangible results. Book now for your place at NGS for Cancer Drug Development and get ready to join the discussion.
“This was truly an excellent meeting. The speakers knew their stuff and generally communicated it with passion and clarity.” American Laboratory
“One of the best NGS workshop tutorials I have seen. Hanson Wade did a great job at bringing the leaders that laid out the workflow of RNA and DNA NGS along with the advantages and challenges.” Viracor-IBT Laboratories
“Perfect organization. Program well planned with sufficient time for networking.” Bristol-Myers Squibb
“I like Hanson Wade’s way of putting together smaller, but more specific meetings. It’s definitely my favourite and would like to come back next year.” EMD Serono
“Hanson Wade put on a very professional, scientific, well organized and pleasant meeting that encouraged positive networking. I loved the speed networking and mastermind groups.” Merck
“Very informative. Greatly facilitated networking and interaction with representatives of academia and industry.” National Cancer Institute
“The conference was perfect. The combination of vendors, academics and industry participants was stimulating. The two days were very worthwhile.” Teradata